Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 5241012, 7 pages
https://doi.org/10.1155/2017/5241012
Research Article

Vitamin D Status, Disease Activity, and Endothelial Dysfunction in Early Rheumatoid Arthritis Patients

1Department of Internal Medicine, Division of Rheumatology, University of Medicine and Pharmacy “Victor Babeş”, Timişoara, Romania
2Division of Rheumatology, Timişoara, Romania
3Department of Internal Medicine, University of Medicine and Pharmacy “Victor Babeş”, Timişoara, Romania
4Department of Pathophysiology, University of Medicine and Pharmacy “Victor Babeş”, Timişoara, Romania
5University of Medicine and Pharmacy “Victor Babeş”, Timişoara, Romania

Correspondence should be addressed to Alexandru Caraba; moc.oohay@abaracxela

Received 29 June 2017; Revised 16 September 2017; Accepted 28 September 2017; Published 22 October 2017

Academic Editor: Zhongjie Shi

Copyright © 2017 Alexandru Caraba et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Majithia and S. A. Geraci, “Rheumatoid arthritis: diagnosis and management,” The American Journal of Medicine, vol. 120, no. 11, pp. 936–939, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Lo Gullo, G. Mandraffino, G. Bagnato et al., “Vitamin D status in rheumatoid arthritis: inflammation, arterial stiffness and circulating progenitor cell number,” PLoS One, vol. 10, no. 8, article e0134602, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Tanasescu, C. Jurcut, R. Jurcut, and C. Ginghina, “Vascular disease in rheumatoid arthritis: from subclinical lesions to cardiovascular risk,” European Journal of Internal Medicine, vol. 20, no. 4, pp. 348–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Peters, D. P. Symmons, D. McCarey et al., “EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 2, pp. 325–331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Insull Jr, “The pathology of atherosclerosis: plaque development and plaque responses to medical treatment,” The American Journal of Medicine, vol. 122, Supplement 1, pp. S3–S14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Lin, J. Liu, M. L. Davies, and W. Chen, “Serum vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis,” PLoS One, vol. 11, no. 1, article e0146351, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Leventis and S. Patel, “Clinical aspects of vitamin D in the management of rheumatoid arthritis,” Rheumatology, vol. 47, no. 11, pp. 1617–1621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Braun-Moscovici, K. Toledano, D. Markovits, A. Rozin, A. M. Nahir, and A. Balbir-Gurman, “Vitamin D level: is it related to disease activity in inflammatory joint disease?” Rheumatology International, vol. 31, no. 4, pp. 493–499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Gatenby, R. Lucas, and A. Swaminathan, “Vitamin D deficiency and risk for rheumatic diseases,” Current Opinion in Rheumatology, vol. 25, no. 2, pp. 184–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Dehghan, S. Rahimpour, H. Soleymani-Salehabadi, and M. B. Owlia, “Role of vitamin D in flare-ups of rheumatoid arthritis,” Zeitschrift für Rheumatologie, vol. 73, no. 5, pp. 461–464, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Neve, A. Corrado, and F. P. Cantatore, “Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis,” Clinical and Experimental Medicine, vol. 14, no. 3, pp. 275–283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Urruticoechea-Arana, M. A. Martin-Martinez, S. Castaneda et al., “Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study,” Arthritis Research & Therapy, vol. 17, no. 1, p. 211, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Aletaha, T. Neogi, A. J. Silman et al., “2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative,” Arthritis & Rheumatism, vol. 62, no. 9, pp. 2569–2581, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Antuna-Puente, E. Disse, R. Rabasa-Lhoret, M. Laville, J. Capeau, and J.-P. Bastard, “How can we measure insulin sensitivity/resistance?” Diabetes & Metabolism, vol. 37, no. 3, pp. 179–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. C. Corretti, T. J. Anderson, E. J. Benjamin et al., “Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force,” Journal of the American College of Cardiology, vol. 39, no. 2, pp. 257–265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. Hong, J. Xu, S. Xu, L. Lian, M. Zhang, and C. Ding, “Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis,” Rheumatology, vol. 53, no. 11, pp. 1–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Skeoch and I. Bruce, “Atherosclerosis in rheumatoid arthritis: is it all about inflammation?” Nature Review Rheumatology, vol. 11, no. 7, pp. 390–400, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Meune, E. Touzé, L. Trinquart, and Y. Allanore, “Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies,” Rheumatology, vol. 48, no. 10, pp. 1309–1313, 2009. View at Publisher · View at Google Scholar
  19. J. A. Avina-Zubieta, J. Thomas, M. Sadatsafavi, A. J. Lehman, and D. Lacaille, “Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies,” Annals of the Rheumatic Diseases, vol. 71, no. 9, pp. 1524–1529, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Mantel, M. Holmqvist, T. Jernberg, S. Wållberg-Jonsson, and J. Askling, “Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome,” European Heart Journal, vol. 36, no. 48, pp. 3413–3422, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Sattar, D. W. McCarey, H. Capell, and I. B. McInnes, “Explaining how ‘high-grade’ systemic inflammation accelerates vascular risk in rheumatoid arthritis,” Circulation, vol. 108, no. 24, pp. 2957–2963, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. H. F. Deluca and M. T. Cantorna, “Vitamin D: its role and uses in immunology,” FASEB Journal, vol. 15, no. 14, pp. 2579–2585, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. M. L. Melamed, E. D. Michos, W. Post, and B. Astor, “25-Hydroxyvitamin D levels and the risk of mortality in the general population,” Archives of Internal Medicine, vol. 168, no. 15, pp. 1629–1637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. H. Kim, S. Sabour, U. N. Sagar, S. Adams, and D. J. Whellan, “Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004),” The American Journal of Cardiology, vol. 102, no. 11, pp. 1540–1544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Maruotti and F. P. Cantatore, “Vitamin D and the immune system,” The Journal of Rheumatology, vol. 37, no. 3, pp. 491–495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Hewison, “An update on vitamin D and human immunity,” Clinical Endocrinology, vol. 76, no. 3, pp. 315–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Lequerre and C. Richez, “Pathophysiology of rheumatoid arthritis,” La Revue du Praticien, vol. 62, no. 8, pp. 1085–1093, 2012. View at Google Scholar
  28. A. Zittermann, S. S. Schleithoff, and R. Koerfer, “Putting cardiovascular disease and vitamin D insufficiency into perspective,” The British Journal of Nutrition, vol. 94, no. 4, pp. 483–492, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Lo Gullo, G. Mandraffino, M. A. Sardo et al., “Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress,” Scandinavian Journal of Rheumatology, vol. 43, no. 3, pp. 184–193, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Zegkos, G. Kitas, and T. Dimitroulas, “Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps,” Therapeutic Advances in Musculoskeletal Disease, vol. 8, no. 3, pp. 86–101, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Welsh, M. J. Peters, and N. Sattar, “Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation,” Arthritis & Rheumatism, vol. 63, no. 7, pp. 1763–1769, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. D. L. Marques, A. T. Dantas, T. S. Fragoso, and A. L. Duarte, “The importance of vitamin D levels in autoimmune diseases,” Revista Brasileira de Reumatologia, vol. 50, no. 1, pp. 67–80, 2010. View at Publisher · View at Google Scholar
  33. E. K. Calton, K. N. Keane, P. Newsholme, and M. J. Soares, “The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies,” PLoS One, vol. 10, no. 11, article e0141770, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. J. J. Cannell, W. B. Grant, and M. F. Holick, “Vitamin D and inflammation,” Dermato-Endocrinology, vol. 6, no. 1, article e983401, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Rehman and M. Sajid Hamid Akash, “Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?” Journal of Biomedical Science, vol. 23, no. 1, p. 87, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. U. J. Haque, J. M. Bathon, and J. T. Giles, “Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis,” Arthritis Care & Research, vol. 64, no. 10, pp. 1497–1504, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Janus, E. Szahidewicz-Krupska, G. Mazur, and A. Doroszko, “Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders,” Mediators of Inflammation, vol. 2016, Article ID 3634948, 10 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Rossini, S. Maddali Bongi, G. La Montagna et al., “Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability,” Arthritis Research & Therapy, vol. 12, no. 6, p. R216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. El-Barbary, M. S. Hussein, E. M. Rageh, S. A. Essa, and H. A. Zaytoun, “Vitamin D receptor gene polymorphism in rheumatoid arthritis and its association with atherosclerosis,” Egyptian Rheumatology Rehabilitation, vol. 42, pp. 145–152, 2015. View at Publisher · View at Google Scholar
  40. M. Cutolo, K. Otsa, K. Laas et al., “Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe,” Clinical and Experimental Rheumatology, vol. 24, no. 6, pp. 702–704, 2006. View at Google Scholar
  41. A. D. Turhanoglu, H. Guler, Z. Yonden, F. Aslan, A. Mansuroglu, and C. Ozer, “The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis,” Rheumatology International, vol. 31, no. 7, pp. 911–914, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Attar, “Vitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia,” Saudi Medical Journal, vol. 33, no. 5, pp. 520–525, 2012. View at Google Scholar
  43. R. Sharma, R. Saigal, L. Goyal et al., “Estimation of vitamin D levels in rheumatoid arthritis patients and its correlation with the disease activity,” The Journal of the Association of Physicians of India, vol. 62, no. 8, pp. 678–681, 2014. View at Google Scholar
  44. O. Tarcin, O. G. Yavuz, B. Ozben et al., “Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 10, pp. 4023–4030, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. V. Hirschler, G. Maccallinni, T. Gilligan et al., “Association of vitamin D with insulin resistance in Argentine boys: a pilot study,” Journal Pediatric Biochemistry, vol. 2, no. 2, pp. 091–099, 2016. View at Publisher · View at Google Scholar
  46. I. Miñambres, J. L. Sanchez-Quesada, and A. Pérez, “The association between hypovitaminosis D and metabolic syndrome: current understanding,” Clinical Lipidology, vol. 10, no. 6, pp. 513–524, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. P. T. McSorley, P. M. Bell, I. S. Young et al., “Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial,” Diabetic Medicine, vol. 22, no. 6, pp. 703–710, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Ferraz-Amaro, C. González-Juanatey, R. López-Mejias, L. Riancho-Zarrabeitia, and M. A. González-Gay, “Metabolic syndrome in rheumatoid arthritis,” Mediators of Inflammation, vol. 2013, Article ID 710928, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. A. C. Borges, T. Feres, L. M. Vianna, and T. B. Paiva, “Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine,” Hypertension, vol. 34, no. 4, Part 2, pp. 897–901, 1999. View at Publisher · View at Google Scholar
  50. K. L. Jablonski, M. Chonchol, G. L. Pierce, A. E. Walker, and D. R. Seals, “25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults,” Hypertension, vol. 57, no. 1, pp. 63–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Ranganathan, S. Khalatbari, S. Yalavarthi, W. Marder, R. Brook, and M. J. Kaplan, “Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis,” The Journal of Rheumatology, vol. 40, no. 9, pp. 1529–1534, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. P. H. Dessein and B. I. Joffe, “Insulin resistance and impaired beta cell function in rheumatoid arthritis,” Arthritis & Rheumatism, vol. 54, no. 9, pp. 2765–2775, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. G. La Montagna, F. Cacciapuoti, R. Buono et al., “Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis,” Diabetes & Vascular Disease Research, vol. 4, no. 2, pp. 130–135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. L. de Groot, N. A. Jager, J. Westra et al., “Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?” Rheumatology, vol. 54, no. 7, pp. 1257–1261, 2015. View at Publisher · View at Google Scholar · View at Scopus